Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60077344%3A_____%2F23%3A00572379" target="_blank" >RIV/60077344:_____/23:00572379 - isvavai.cz</a>
Alternative codes found
RIV/68378050:_____/23:00572379 RIV/00216224:14310/23:00130433 RIV/62156489:43210/23:43923118 RIV/62157124:16170/23:43881034 RIV/00027162:_____/23:N0000026
Result on the web
<a href="https://www.science.org/doi/10.1126/sciimmunol.ade0958" target="_blank" >https://www.science.org/doi/10.1126/sciimmunol.ade0958</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1126/sciimmunol.ade0958" target="_blank" >10.1126/sciimmunol.ade0958</a>
Alternative languages
Result language
angličtina
Original language name
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Original language description
Emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants diminishes the efficacy of vaccines and antiviral monoclonal antibodies. Continued development of immunotherapies and vaccine immunogens resilient to viral evolution is therefore necessary. Using coldspot-guided antibody discovery, a screening approach that focuses on portions of the virus spike glycoprotein that are both functionally relevant and averse to change, we identified human neutralizing antibodies to highly conserved viral epitopes. Antibody fp.006 binds the fusion peptide and cross-reacts against coronaviruses of the four genera, including the nine human coronaviruses, through recognition of a conserved motif that includes the S2 ' site of proteolytic cleavage. Antibody hr2.016 targets the stem helix and neutralizes SARS-CoV-2 variants. Antibody sd1.040 binds to subdomain 1, synergizes with antibody rbd.042 for neutralization, and, similar to fp.006 and hr2.016, protects mice expressing human angiotensin-converting enzyme 2 against infection when present as a bispecific antibody. Thus, coldspot-guided antibody discovery reveals donor-derived neutralizing antibodies that are crossreactive with Orthocoronavirinae, including SARS-CoV-2 variants.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10607 - Virology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
SCI IMMUNOL
ISSN
2470-9468
e-ISSN
2470-9468
Volume of the periodical
8
Issue of the periodical within the volume
81
Country of publishing house
US - UNITED STATES
Number of pages
18
Pages from-to
eade0958
UT code for WoS article
000957715600004
EID of the result in the Scopus database
2-s2.0-85148880986